(Q46588624)
Statements
1 reference
Phase II trial of tesmilifene plus mitoxantrone and prednisone for hormone refractory prostate cancer: high subjective and objective response in patients with symptomatic metastases (English)
1 reference
1 reference
Raghavan D
1 reference
Brandes LJ
1 reference
Klapp K
1 reference
Snyder T
1 reference
Styles E
1 reference
Tsao-Wei D
1 reference
Lieskovsky G
1 reference
Ramsey EW
1 reference
1 November 2005
1 reference
1 reference
174
1 reference
5
1 reference
1808-13; discussion 1813
1 reference
Identifiers
1 reference